Medicare Enrolled

Dr. Gary Lu, M.D., PH.D

Hematology & Oncology · Denton, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
2600 SCRIPTURE ST, Denton, TX 76201
9403821022
In practice since 2013 (13 years)
NPI: 1588906457 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lu

Dr. Gary Lu is a hematology & oncology in Denton, TX, with 13 years in practice. Based on federal Medicare data, Dr. Lu performed 73,791 Medicare services across 2,084 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lu received a total of $3,194 from 27 pharmaceutical and/or device companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ Top 12% volume in TX$ $3,194 industry payments

Medicare Practice Summary

Medicare Utilization ↗
73,791
Medicare services
Top 12% in TX for hematology & oncology
2,084
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,676 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)17,340$0$5
Pembrolizumab injection (Keytruda)12,200$43$137
Darbepoetin injection (Aranesp) for anemia11,965$2$20
Iron sucrose injection (Venofer)10,200$0$2
Denosumab injection (Prolia/Xgeva)6,420$18$66
Anti-nausea injection (fosaprepitant)4,650$0$5
Dexamethasone injection (steroid)1,650$0$1
Contrast dye for imaging (iodine-based)1,605$0$3
Injection, granisetron hydrochloride, 100 mcg1,240$0$24
Complete blood count (CBC) with differential626$8$36
Comprehensive metabolic blood panel602$10$64
Anti-nausea injection (Aloxi/palonosetron)590$1$114
Office visit, established patient (30-39 min)552$94$368
Blood draw (venipuncture)549$8$20
Injection of additional new drug or substance into vein502$12$108
Administration of chemotherapy into vein, 1 hour or less339$99$707
Injection, fluorouracil, 500 mg329$2$13
Drug injection, under skin or into muscle190$11$96
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less170$48$313
Injection, carboplatin, 50 mg163$2$300
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less156$22$157
Injection, zoledronic acid, 1 mg149$7$431
Injection, diphenhydramine hcl, up to 50 mg143$1$7
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour125$16$100
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle119$56$211
Administration of additional new drug or substance into vein, 1 hour or less107$49$344
Leuprolide acetate (for depot suspension), 7.5 mg86$133$3,675
Ferritin level test (iron stores)71$13$60
Iron level test70$6$27
Iron binding capacity test70$8$35
Administration of chemotherapy into vein, each additional hour69$22$161
Infusion, normal saline solution , 1000 cc64$2$19
New patient office visit (45-59 min)63$121$565
Infusion into a vein for hydration, each additional hour50$9$75
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle49$26$145
Hospital follow-up visit, moderate complexity39$62$247
Microscopic examination for white blood cells with manual cell count38$4$22
Complete blood count (CBC), automated38$6$34
Reticulated (young) platelet measurement35$35$143
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l32$123$500
Office visit, established patient, complex (40-54 min)31$122$496
Infusion, normal saline solution, sterile (500 ml = 1 unit)31$1$19
Injection of drug or substance into vein30$27$247
Office visit, established patient (20-29 min)28$56$250
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion27$15$94
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg26$1$17
Administration of additional new drug or substance into vein using push technique25$41$289
Irrigation of implanted venous access drug delivery device22$19$114
Initial hospital admission, moderate complexity22$101$470
Ct scan of chest with contrast19$43$821
Infusion into a vein for hydration, 31-60 minutes17$25$256
Blood creatinine level16$5$31
Urea nitrogen level to assess kidney function, quantitative16$4$24
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries14$87$657
CT scan of abdomen and pelvis with contrast12$153$1,067
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
24.4% high complexity
71.4% medium
4.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,194
Total received (2018-2024)
Avg $456/year across 7 years
Top 50% in TX for hematology & oncology
27
Companies
59
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,455 (45.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$928 (29.0%)
Other
Charitable contributions, space rental, and other categories
$812 (25.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,043
2023
$74
2022
$1,108
2021
$458
2020
$225
2019
$16
2018
$269

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$862
Astellas Pharma US Inc
$304
E.R. Squibb & Sons, L.L.C.
$207
Novocure GmbH
$200
Eisai Inc.
$195
AstraZeneca Pharmaceuticals LP
$193
Athenex Pharmaceutical Division, LLC
$175
Alexion Pharmaceuticals, Inc.
$150
Sirtex Medical Inc
$135
Rigel Pharmaceuticals, Inc.
$119
Myriad Genetic Laboratories, Inc.
$118
Seagen Inc.
$89
Daiichi Sankyo Inc.
$72
Lilly USA, LLC
$64
Celgene Corporation
$52
PFIZER INC.
$40
Merck Sharp & Dohme LLC
$39
PharmaEssentia USA Corporation
$30
Tempus AI, Inc
$23
Gilead Sciences, Inc.
$21
Kite Pharma, Inc.
$19
GlaxoSmithKline, LLC.
$17
Janssen Pharmaceuticals, Inc
$16
ARRAY BIOPHARMA INC
$16
Incyte Corporation
$15
ABBVIE INC.
$15
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 43.0% of total payments
Associated products mentioned in payments ›
BESREMI · CALQUENCE · CREON · ELIQUIS · ENHERTU · Enhertu · INLYTA · JAKAFI · KEYTRUDA · KISQALI · LUTATHERA · LYNPARZA · Lenvima · OPDIVO · PADCEV · PIQRAY · Pomalyst · PreciseTumor · SIR-Spheres Microspheres · Tavalisse · Trodelvy · Ultomiris · VERZENIO · XALKORI · XARELTO · XTANDI · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (46%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $4 per 100 Medicare services performed
Looking for a hematology & oncology in Denton?
Compare hematology & oncologys in the Denton area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
24
Per 100K population
2.5
County median income
$108,185
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DENTON
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lu is a mixed practice specialist, with above-average Medicare volume (top 12% in TX), and mixed engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lu experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Lu performed 17,340 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lu receive payments from pharmaceutical companies?
Yes. Dr. Lu received a total of $3,194 from 27 companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lu's costs compare to other hematology & oncologys in Denton?
Dr. Lu's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →